The PrEP Access and Coverage Act of 2026 aims to improve access to pre-exposure prophylaxis (PrEP) medications, which are critical in preventing the transmission of HIV. The legislation seeks to eliminate financial barriers that individuals at risk of HIV face in obtaining these medications, thereby promoting public health and reducing the spread of the virus. Key provisions of the act require private insurance plans to cover PrEP medications and related services without any cost-sharing, such as co-pays or deductibles.